Rituximab alone is as effective as associated with steroids on naive patients with generalized myasthenia gravis.

We suggest that RTX alone is as effective as RTX-CS in MG patients, indicating that avoiding steroids could reduce side effects, decrease rescue therapies, and not affect MG outcomes.